Ambien CR, Razadyne ER Paragraph IV Certifications Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Sanofi-Aventis' sleep aid Ambien CR 6.25 mg was filed Feb. 24, according to FDA's May 16 updated list of filings
You may also be interested in...
Sanofi-Aventis Rebates Aim To Accelerate Switch To Ambien CR
Firm is offering concessions to U.S. healthcare providers to switch patients to the extended-release formulation.
Sanofi-Aventis Rebates Aim To Accelerate Switch To Ambien CR
Firm is offering concessions to U.S. healthcare providers to switch patients to the extended-release formulation.
Ambien CR Paragraph IV Certification Filed
The first ANDA with a Paragraph IV certification for Ambien CR was submitted Jan. 19, according to FDA's certifications list, which was updated March 17